New study uses weekly surveys to monitor cancer Patients' symptoms remotely

NCT ID NCT05974150

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is gathering information from 25 adults with breast, lung, ovarian, multiple myeloma, or acute myeloid leukemia who are on active treatment. Participants fill out a short online survey each week for at least 12 weeks to report how they are feeling. The goal is to build a real-world dataset that could help improve symptom monitoring and care for future patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better understand and manage symptoms in real time for people with these cancers.
What could go wrong
This is a small, early-stage registry study (25 participants) that only collects data—it does not test a new treatment or directly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOGENOUS LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic Mercy Hospital

    RECRUITING

    Canton, Ohio, 44708, United States

  • Duke

    COMPLETED

    Durham, North Carolina, 27707, United States

  • Northshore University Health System

    RECRUITING

    Evanston, Illinois, 31024, United States

  • Tri-County Hematology & Oncology Associates, Inc.

    RECRUITING

    Massillon, Ohio, 44646, United States

  • Univeristy of North Carolina at Chapel Hill

    COMPLETED

    Chapel Hill, North Carolina, 27599, United States

  • University Hospitals Seidman Cancer Center

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • Yale Cancer Center

    COMPLETED

    New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.